The most relevant finding of our study was the strong prognostic role of FGD3 expression as evaluated by IHC on both DFS and OS, in accordance with the few previous studies [3,4,5,9] that pointed out its value in breast cancer patients. The gene discussed is FGD3; the disease is breast carcinoma.